1. Home
  2. ACXP vs OBLG Comparison

ACXP vs OBLG Comparison

Compare ACXP & OBLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACXP
  • OBLG
  • Stock Information
  • Founded
  • ACXP 2017
  • OBLG 2000
  • Country
  • ACXP United States
  • OBLG United States
  • Employees
  • ACXP N/A
  • OBLG N/A
  • Industry
  • ACXP Biotechnology: Pharmaceutical Preparations
  • OBLG Computer Software: Programming Data Processing
  • Sector
  • ACXP Health Care
  • OBLG Technology
  • Exchange
  • ACXP Nasdaq
  • OBLG Nasdaq
  • Market Cap
  • ACXP 6.8M
  • OBLG 5.5M
  • IPO Year
  • ACXP 2021
  • OBLG N/A
  • Fundamental
  • Price
  • ACXP $4.24
  • OBLG $2.50
  • Analyst Decision
  • ACXP Strong Buy
  • OBLG
  • Analyst Count
  • ACXP 3
  • OBLG 0
  • Target Price
  • ACXP $143.67
  • OBLG N/A
  • AVG Volume (30 Days)
  • ACXP 89.0K
  • OBLG 94.5K
  • Earning Date
  • ACXP 11-12-2025
  • OBLG 11-06-2025
  • Dividend Yield
  • ACXP N/A
  • OBLG N/A
  • EPS Growth
  • ACXP N/A
  • OBLG N/A
  • EPS
  • ACXP N/A
  • OBLG N/A
  • Revenue
  • ACXP N/A
  • OBLG $2,355,000.00
  • Revenue This Year
  • ACXP N/A
  • OBLG N/A
  • Revenue Next Year
  • ACXP N/A
  • OBLG N/A
  • P/E Ratio
  • ACXP N/A
  • OBLG N/A
  • Revenue Growth
  • ACXP N/A
  • OBLG N/A
  • 52 Week Low
  • ACXP $3.80
  • OBLG $1.91
  • 52 Week High
  • ACXP $43.20
  • OBLG $5.50
  • Technical
  • Relative Strength Index (RSI)
  • ACXP 51.39
  • OBLG 40.82
  • Support Level
  • ACXP $3.97
  • OBLG $2.46
  • Resistance Level
  • ACXP $4.85
  • OBLG $2.87
  • Average True Range (ATR)
  • ACXP 0.35
  • OBLG 0.26
  • MACD
  • ACXP -0.02
  • OBLG 0.02
  • Stochastic Oscillator
  • ACXP 23.45
  • OBLG 10.29

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.

About OBLG Oblong Inc.

Oblong Inc is a provider of patented multi-stream collaboration products and managed services for network solutions and video collaboration. The company's flagship product Mezzanine is the technology platform that defines computing: simultaneous multi-user, multi-screen, multi-device, and multi-location for dynamic and immersive visual collaboration. Mezzanine transforms routine meetings and workflows into agile, engaging experiences by making data visible and accessible in a collaborative setting. The mezzanine enables multiple, concurrent pieces of content to be shared, manipulated, created, and captured across distance. It serves various industries including aerospace, consulting, executive search, broadcast media, technology, financial services, education, healthcare, and real estate.

Share on Social Networks: